Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...
By Maggie Fick and Lucy Raitano LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far in March and are on track for ...
Resolutions adopted at the Annual General Meeting Financial year 2024 and remuneration Approval of the Company's statutory Annual Report 2024 and distribution of profits according to the statutory ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
3d
Zacks Investment Research on MSNNovo Nordisk Down 15% in March: Is This a Buying Opportunity?Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also ...
The issuer is solely responsible for the content of this announcement.
Novo Nordisk (NYSE:NVO) submits a supplemental New Drug Application (sNDA) to the FDA seeking to included data from the DEVOTE... Investing.com – Denmark stocks were higher after the close on ...
Novo Holdings today announced its participation in a €23 million Series A round for Tribune Therapeutics ('Tribune'). The round was led by new investor LifeArc Ventures and joined by Novo Holdings, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results